【Financial Focus】Technology Achieves Multiple Breakthrough Developments, Commercialization Process Accelerates, Institutions Claim China's Brain-Computer Interface Industry is Expected to Usher in a DeepSeek Moment!

People’s Financial News, March 25 — Recently, brain-computer interface technology has achieved multiple breakthrough advancements, marking a critical phase of industry development moving toward practical implementation. This cutting-edge technology, once only imagined in science fiction, is gradually entering diverse fields such as healthcare and consumer electronics, ushering in a new era of human-computer interaction. The National Medical Products Administration recently approved the world’s first invasive brain-computer interface medical device, a milestone for China’s invasive brain-computer interface industry transitioning from “technology validation” to “commercialization.” Additionally, the National Healthcare Security Administration proactively coordinated and provided services to assign medical insurance codes to this product, successfully bridging the key gap from approval to clinical application.

On the policy front, regulations related to brain-computer interfaces continue to be released, and industry standards are becoming clearer. The 2026 government work report listed brain-computer interfaces as a key future industry to be cultivated. The “14th Five-Year Plan” explicitly emphasizes forward-looking development of future industries, promoting brain-computer interfaces and similar technologies as new drivers of economic growth. From a national strategic project, brain-computer interfaces are evolving into a strategic future industry, highlighting industrialization and economic value.

Currently, brain-computer interface technology mainly falls into three categories: non-invasive, semi-invasive, and invasive. Non-invasive techniques, due to their safety, convenience, and lower cost, are rapidly popularizing in consumer electronics and emotion monitoring; semi-invasive methods balance signal quality and safety, gradually being applied in medical scenarios such as epilepsy treatment and rehabilitation assistance; invasive techniques, though requiring surgical implantation, offer extremely high signal precision and are central to breakthroughs in the rehabilitation of severely paralyzed patients and neurological disease treatment.

With the launch of related core products, the brain-computer interface industry is transitioning from technological exploration to a critical stage of large-scale commercial application, with significant growth potential. McKinsey predicts that the global market for brain-computer interface medical applications could reach $40 billion by 2030 and $145 billion by 2040. According to China Academy of Information and Communications Technology, China’s brain-computer interface industry is expected to grow to between 10 billion and 14 billion yuan by 2030. Data shows that in 2025, China completed 24 financing events in the brain-computer interface field, with total funding exceeding 5 billion yuan—an explosive increase from 200 million yuan in 2024, reaching a recent high. CITIC Securities believes that the domestic brain-computer interface industry will enter a “DeepSeek” moment. Driven by “policy + capital + technology,” the commercialization process is accelerating, and the industry is expected to evolve from “neurorehabilitation” to “cognitive enhancement” and eventually to “brain integration.”

Three investment themes are recommended: 1. Leading companies with technological breakthroughs or excellent clinical results in innovative fields; 2. Leading companies with diversified application scenarios and strong commercialization sales capabilities in non-invasive fields; 3. Leading companies with advanced CDMO/CRO capabilities. AVIC Securities states that the brain-computer interface industry is at a critical window transitioning from “technology validation” to “commercialization,” with future industry leadership contests and multi-scenario demand opening growth space. It is advised to focus on the latest developments and frontier companies in three categories of brain-computer interfaces.